AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

17,18 TSLP is released in response to multiple triggers (including allergens, viruses and other airborne particles) ...

Joseph Han, vice chair of Rhinology & Endoscopic Sinus and Skull Base Surgery ... whose lives are disrupted by this ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...

Known as Aspirin-Exacerbated Respiratory Disease (AERD), this condition is marked by a combination of nasal polyps ... Dr ...

Multiple organisms have been isolated from infected sinuses. However, it is important to note that "normal flora" has been cultured from healthy uninfected sinuses. "Normal flora" include ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...